Clostridium Difficile Infection Recurrence Clinical Trials

15 clinical trials for Clostridium Difficile Infection Recurrence across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection — RECRUITING · PHASE2
• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — RECRUITING · PHASE3
• Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile — RECRUITING · NA
• Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics — RECRUITING
• A Multi-center, Single-arm Trial Exploring the Safety and Clinical Effectiveness of RBX2660 Administered by Colonoscopy to Adults With Recurrent Clostridioides Difficile Infection — COMPLETED · PHASE3
• Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients — TERMINATED · PHASE2
• Bacillus Velezensis DSM 33864 for Reduction of the Risk of Recurrent Clostridioides Difficile Infections — WITHDRAWN · NA
• Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection — COMPLETED · PHASE2
• Oral Vancomycin for Secondary Prophylaxis of Clostridium Difficile Infection (CDI) — TERMINATED · PHASE4
• Real-world Evaluation of Bezlotoxumab for the Management of Clostridioides Difficile Infection — COMPLETED
• A Study of ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI) — COMPLETED · PHASE1
• Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff — COMPLETED · PHASE2
• Bezlotoxumab (BEZLO) In Addition To Standard Of Care (SOC) Vancomycin For The Treatment of Multi-Recurrent Clostridium Difficile Infection — COMPLETED · PHASE4
• Bezlotoxumab Efficacy and Tolerability in Cancer Patient — OTHER · PHASE4
• Treatment for Clostridium-difficile Infection With IMM529 — TERMINATED · PHASE1

Refine this search